Update: Teva, Sanofi Shares Jump as Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease
In This Article:
(Updates to reflect stock price movement in the headline and body of the story.) Teva Pharmaceuti
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Terms and Privacy Policy